HCV resistance prediction from genotype (version 1.

0)

I. General information

Patient: Study ID:

Birth date: Viral load:
Sample received: Sample collected:
Sample ID: Consensus_for_segment_ Predicted subtype: NS5B: 4f (89.54%)
HEPATITIS_c_1a_for_spe
cimen_SANO005_NS5B
Sample type: Report date: 26.05.2020
Physician: Reported by:

II. Sequence information

NS5B codons covered 225 - 348 (Important positions not covered: 368,411,414,448,553,554,556)

NS5B region (w.r.t. H267Y, Y285F, K309R, N310D, A335?, V338A

EF589161)
NS5B region (w.r.t. H77) S231R, T235V, A238E, I239V, D246E, Q248E, A249T, V251K, A252V, K254S, S255A, L266M,
T267Y, R270K, E272D, N273L, L285F, C289F, Y296F, I297L, R300T, C303A, R304K, Q309R,
C316N, C324A, A327D, Q330D, A333R, A334R, S335?, R337G

III. Resistance analysis

Drug Prediction Scored Mutations

Dasabuvir not licensed for subtype not available

Sofosbuvir susceptible none

Comments:

______________________
(signature)

Contact: info@mpi-inf.mpg.de
www.geno2pheno.org